News | September 23, 2010

Injunction Awarded in Patent Infringement Lawsuit

September 23, 2010 – The United States District Court for the District of New Hampshire entered a permanent injunction in a patent infringement lawsuit between two medical device companies.

The court issued an order permanently enjoining HemCon from infringing on Marine Polymer’s patent concerning biocompatible polymers known as “p-GlcNAc.” The polymers are the essential ingredient of hemostatic products designed to prevent severe blood loss. Both companies make products containing the patented technology and directly compete in the civilian market.

Effective as of September 16, 2010, the order prohibits HemCon from making, using, selling distributing or importing into the United States certain products that infringe Marine Polymer’s patent, such as the HemCon Bandage, Chitoflex and Dental Dressings.

The ruling comes on the heels of a verdict by a federal jury in April awarding more than $29.4 million in damages to Marine Polymer for HemCon’s past infringement.

“We are very pleased with the Court’s recent orders confirming the validity and enforceability of our patent, and we aim to make sure that all those acting in concert with HemCon are aware of the terms of the injunction as entered by the Court,” said Sergio Finkielsztein, President and CEO of Marine Polymer. He further stated that his company intends to vigorously oppose any appeal filed by HemCon before the Federal Circuit Court of Appeals.

For more information please visit: www.syvek.com

Related Content

Vascular Solutions, Teleflex
Feature | December 07, 2016
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc.
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices| September 12, 2016
September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16.
nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management| August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
Rex medical, Closer Vascular Sealing System, VSS, vascular closure, bioresorbable vascular closure device

A close up view of the Rex Medical Closer Vascular Sealing System components.

Technology | Vascular Closure Devices| August 03, 2016
August 3, 2016 — The U.S.
Vivasure Medical, PerQSeal, vascular closure device, CE Mark
News | Vascular Closure Devices| January 18, 2016
Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully bioabsorbable...
News | Hemostasis Management| January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...
News | Vascular Closure Devices| December 16, 2015
Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from...
platelet-like particles, PLPs, clotting, substitute, Carver, Lyon, NIBIB

Cartoon representation of a deformable platelet-like particle with fibrin nanobodies attached

Feature | Antiplatelet and Anticoagulation Therapies| July 13, 2015
Researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles...
News | March 30, 2015
The Medicines Company announced that the European Commission has granted marketing authorization for two acute care...
Overlay Init